SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
about
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cellsSirtuins in metabolism, DNA repair and cancerCopper activates HIF-1α/GPER/VEGF signalling in cancer cellsLong-term exposure to a 'safe' dose of bisphenol A reduced protein acetylation in adult rat testesEpigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancerG-1 Inhibits Breast Cancer Cell Growth via Targeting Colchicine-Binding Site of Tubulin to Interfere with Microtubule Assembly.SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.The membrane-type estrogen receptor G-protein-coupled estrogen receptor suppresses lipopolysaccharide-induced interleukin 6 via inhibition of nuclear factor-kappa B pathway in murine macrophage cells.GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.Estrogens regulate life and death in mitochondria.miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1.The lauric acid-activated signaling prompts apoptosis in cancer cells.Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways.GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer.SIRT1 contributes to neuroendocrine differentiation of prostate cancer.SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression
P2860
Q27322202-7FC9BED6-22B2-447F-A907-AA454F661BACQ27340035-E0C0121C-EE54-4669-8A43-F8471D43A50CQ28070892-2DBED784-B2F4-4708-8459-1665E5CE262EQ28601324-77BED443-3FB7-4AD8-B380-223A2BE37162Q28817761-D097D791-A529-4E73-823B-1CF80CDDF99BQ33640340-B45BA860-6585-40FF-8368-3EAD2C883454Q36297086-AC5A3F1A-D626-486E-ACAD-316570FA16C9Q37029449-6ADEB353-6B9B-43CF-91AF-6B93B21338FBQ38696844-2E7CCD0B-FCD6-4D94-96D2-D0BB64165951Q38762482-12F70B24-6574-4608-B127-EE5B94640D40Q39236899-89D45E71-8FB5-4130-94E4-2EE56C0DFEF9Q41525784-D3027A44-AC3D-4AF2-AFAC-36F871A63DB5Q41724625-35E32691-8EC7-43F5-AC75-97CF5D426056Q45825160-D86B7353-5F97-4958-80C6-B7FA03F71367Q47227722-F96734B0-D6B3-4366-A4A7-F7F0A90EF256Q49522217-FAA130B6-5879-4AD3-8852-48E6C1D0CEB9Q57490805-1FD6BD62-8B0B-4AAD-AB51-29655FC114FA
P2860
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
@ast
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
@en
type
label
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
@ast
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
@en
prefLabel
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
@ast
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
@en
P2093
P2860
P356
P1476
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer
@en
P2093
A Scarpelli
D C Rigiracciolo
E M De Francesco
M Maggiolini
M Pellegrino
P De Marco
S Abonante
P2860
P356
10.1038/CDDIS.2015.201
P577
2015-07-30T00:00:00Z